Neimeth cuts share premium to N390 million, transfers N1.99 billion to reserves 

Neimeth International Pharmaceuticals has reduced its share premium account to N390 million. The company concurrently transferred N1.99 billion to its reserves as part of a capital restructuring process. This financial adjustment aims to strengthen the firm's balance sheet and manage its capital structure effectively for future operations.